» Articles » PMID: 28620157

A Novel Cell Membrane Affinity Sample Pretreatment Technique for Recognition and Preconcentration of Active Components from Traditional Chinese Medicine

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jun 17
PMID 28620157
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We describe a novel biomembrane affinity sample pretreatment technique to quickly screen and preconcentrate active components from traditional Chinese medicine (TCM), which adopts cell membrane coated silica particles (CMCSPs) as affinity ligands which benefit the biomembrane's ability to maximize simulation of drug-receptor interactions in vivo. In this study, the prepared CMCSPs formed by irreversible adsorption of fibroblast growth factor receptor 4 (FGFR4) cell membrane on the surface of silica were characterized using different spectroscopic and imaging instruments. Drug binding experiments showed the excellent adsorption rate and adsorption capacity of FGFR4/CMCSPs compared with non-coated silica particles. The FGFR4/CMCSPs were used as solid-phase extraction sorbents to pretreat the TCM Aconitum szechenyianum Gay. The resultant FGFR4/CMCSPs exhibited good performance. In addition, high selectivity and recognition ability of the FGFR4/CMCSPs were determined by selectivity experiments. Four alkaloid were screened and identified, one of these alkaloid, napellonine, showed favorable anti-tumor activity in preliminary pharmacological verification trials including cell proliferation and molecular docking assays. The proposed cell membrane affinity sample pretreatment method is a reliable, effective and time-saving method for fast screening and enriching active compounds and can be extended to pretreat other TCMs as leading compounds resources.

Citing Articles

Erythrocyte membrane affinity chromatography, solid-phase extraction and UPLC-QTOF-MS/MS to screen active ingredients of Buyang Huanwu decoction.

Yu A, Zheng H, Yan X, Wang S, Shen X, Zheng H RSC Adv. 2022; 9(50):29217-29224.

PMID: 35528420 PMC: 9071827. DOI: 10.1039/c9ra03447a.


Integrated Strategy of Network Pharmacological Prediction and Experimental Validation Elucidate Possible Mechanism of Bu-Yang Herbs in Treating Postmenopausal Osteoporosis via ESR1.

Xia H, Liu J, Yang W, Liu M, Luo Y, Yang Z Front Pharmacol. 2021; 12:654714.

PMID: 34045964 PMC: 8144472. DOI: 10.3389/fphar.2021.654714.

References
1.
Xie X, Chen L, Pan X, Wang S . Synthesis of magnetic molecularly imprinted polymers by reversible addition fragmentation chain transfer strategy and its application in the Sudan dyes residue analysis. J Chromatogr A. 2015; 1405:32-9. DOI: 10.1016/j.chroma.2015.05.068. View

2.
Huang S, Tung C, Fulop F, Li J . Developing a QSAR model for hepatotoxicity screening of the active compounds in traditional Chinese medicines. Food Chem Toxicol. 2015; 78:71-7. DOI: 10.1016/j.fct.2015.01.020. View

3.
Ye Y, Hu S, Shi Y, Zhang X, Zhou Y, Zhao C . Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer. Oncol Rep. 2013; 30(6):2777-84. DOI: 10.3892/or.2013.2796. View

4.
Qu W, Mou Z, Cui H, Zhang Z . Analysis of fatty acids in A. szechenyianum Gay. by microwave-assisted extraction and gas chromatography-mass spectrometry. Phytochem Anal. 2010; 22(3):199-204. DOI: 10.1002/pca.1265. View

5.
Yuan J, Zhang Z, Kang X, Liu J . LC-MS analysis for the components captured by ECV304 cell from extract of Aconitum szechenyianum Gay. Biomed Chromatogr. 2008; 23(4):406-11. DOI: 10.1002/bmc.1131. View